Verve Therapeutics, Inc. Contracts & Agreements

42 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Summary of Non-Employee Director Compensation Program
Compensation Agreements
Verve Therapeutics, Inc.
Biotechnology
2025
Advisor Agreement, dated May 30, 2024, by and between the Registrant and Andrew Bellinger
Verve Therapeutics, Inc.
Biotechnology
MA
2024
Separation Agreement, dated May 30, 2024, by and between the Registrant and Andrew Bellinger
Separation Agreements
Verve Therapeutics, Inc.
Biotechnology
MA
2024
2024 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2024
Form of Restricted Stock Unit Agreement under 2024 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2024
Form of Nonstatutory Stock Option Agreement under 2024 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
2024
Summary of Non-Employee Director Compensation Program
Compensation Agreements
Verve Therapeutics, Inc.
Biotechnology
2024
License Agreement, dated October 4, 2021, by and between the Registrant and Novartis Pharma AG, as amended
License Agreements
Verve Therapeutics, Inc.
Biotechnology
MA
2024
Employment Agreement, dated as of June 11, 2021, between the Registrant and Andrew Bellinger, M.D., Ph.D., as amended
Employment Agreements
Verve Therapeutics, Inc.
Biotechnology
MA
2024
Stock Purchase Agreement, dated as of November 28, 2023, by and between the Registrant and Eli Lilly and Company
Stock Agreements
Verve Therapeutics, Inc.
Biotechnology
IN
2024
Underwriting Agreement, dated November 28, 2023, by and among the Company and Jefferies LLC, Guggenheim Securities, LLC, William Blair & Company, L.L.C., BMO Capital Markets Corp....
Underwriting Agreements
Verve Therapeutics, Inc.
Biotechnology
NY
2023
Second Amendment to Lease, dated as of June 17, 2022, by and between the Registrant and ARE-MA Region No. 87 Tenant, LLC
Lease Agreements
Verve Therapeutics, Inc.
Biotechnology
2022
Underwriting Agreement, dated July 20, 2022, by and among the Company and J.P. Morgan Securities LLC, Jefferies LLC, Guggenheim Securities, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Verve Therapeutics, Inc.
Biotechnology
NY
2022
Employment Agreement, dated as of November 26, 2021, between the Registrant and Allison Dorval
Employment Agreements
Verve Therapeutics, Inc.
Biotechnology
MA
2022
First Amendment to Lease, dated as of January 4, 2022, by and between the Registrant and ARE-MA Region No. 87 Tenant, LLC
Lease Agreements
Verve Therapeutics, Inc.
Biotechnology
2022
Summary of Non-Employee Director Compensation Program
Compensation Agreements
Verve Therapeutics, Inc.
Biotechnology
2022
Form of Restricted Stock Unit Agreement under the 2021 Stock Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2022
Form of Stock Option Agreement under the 2021 Stock Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
2022
Description of Securities Registered under Section 12 of the Exchange Act
Verve Therapeutics, Inc.
Biotechnology
2022
Lease by and between Verve Therapeutics, Inc. and ARE-MA Region No. 87 Tenant, LLC, dated
Lease Agreements
Verve Therapeutics, Inc.
Biotechnology
2021
Employment Agreement, dated as of June 11, 2021, between the Registrant and Andrew Bellinger, M.D., Ph.D
Employment Agreements
Verve Therapeutics, Inc.
Biotechnology
MA
2021
Employment Agreement, dated as of June 11, 2021, between the Registrant and Andrew Ashe, J.D
Employment Agreements
Verve Therapeutics, Inc.
Biotechnology
MA
2021
Employment Agreement, dated as of June 11, 2021, between the Registrant and Sekar Kathiresan, M.D
Employment Agreements
Verve Therapeutics, Inc.
Biotechnology
MA
2021
Summary of Non-Employee Director Compensation Program
Compensation Agreements
Verve Therapeutics, Inc.
Biotechnology
2021
Amended and Restated 2021 Employee Stock Purchase Plan
Stock Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Form of Restricted Stock Unit Agreement under the 2021 Stock Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Form of Stock Option Agreement under the 2021 Stock Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
2021
2021 Stock Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Form of Underwriting Agreement
Underwriting Agreements
Verve Therapeutics, Inc.
Biotechnology
NY
2021
Second Amended and Restated Investors Rights Agreement, dated as of January 14, 2021, by and among the Registrant and the other parties thereto
Investor Rights Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Specimen Stock Certificate evidencing the shares of common stock
Stock Agreements
Verve Therapeutics, Inc.
Biotechnology
2021
2018 Equity Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Form of Stock Option Agreement under the 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Collaboration and License Agreement, dated as of April 3, 2019, by and between the Registrant and Beam Therapeutics Inc
Collaboration Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Amended and Restated Development and Option Agreement, dated as of October 6, 2020, by and between the Registrant and Acuitas Therapeutics, Inc
Development Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Non-Exclusive License Agreement, dated as of October 14, 2020, by and between the Registrant and Acuitas Therapeutics, Inc
License Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021
Cas9 License Agreement, dated as of March 15, 2019, by and among the Registrant, The President and Fellows of Harvard College and The Broad Institute, Inc., as amended
License Agreements
Verve Therapeutics, Inc.
Biotechnology
MA
2021
Sublease, dated as of April 13, 2020, by and between the Registrant and Foghorn Therapeutics Inc., as amended
Lease Agreements
Verve Therapeutics, Inc.
Biotechnology
2021
Offer Letter, dated as of April 16, 2019, by and between the Registrant and Sekar Kathiresan, M.D
Verve Therapeutics, Inc.
Biotechnology
MA
2021
Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Ashe, J.D
Verve Therapeutics, Inc.
Biotechnology
2021
Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Bellinger, M.D., Ph.D
Verve Therapeutics, Inc.
Biotechnology
2021
Form of indemnification agreement between the Registrant and each of its executive officers and directors
Indemnification Agreements
Verve Therapeutics, Inc.
Biotechnology
DE
2021